The use of pharmacodynamic results for recommended phase II decision making in oncology clinical trials
- DOI
- 10.1007/s00280-026-04924-7
- Published
- 2026-07-06
- Container
- Cancer Chemotherapy and Pharmacology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s00280-026-04924-7,
title = {The use of pharmacodynamic results for recommended phase II decision making in oncology clinical trials},
author = {A. C. Kanhailal and M. J. J. Lucassen and T. Schutte and W. Zwart and A. D. R. Huitema and N. Steeghs},
year = {2026},
journal = {Cancer Chemotherapy and Pharmacology},
doi = {10.1007/s00280-026-04924-7},
url = {https://doi.org/10.1007/s00280-026-04924-7}
}RIS
TY - JOUR TI - The use of pharmacodynamic results for recommended phase II decision making in oncology clinical trials AU - A. C. Kanhailal AU - M. J. J. Lucassen AU - T. Schutte AU - W. Zwart AU - A. D. R. Huitema AU - N. Steeghs PY - 2026 JO - Cancer Chemotherapy and Pharmacology DO - 10.1007/s00280-026-04924-7 UR - https://doi.org/10.1007/s00280-026-04924-7 ER -
APA
Kanhailal, A. C., Lucassen, M. J. J., Schutte, T., Zwart, W., Huitema, A. D. R., & Steeghs, N. (2026). The use of pharmacodynamic results for recommended phase II decision making in oncology clinical trials. Cancer Chemotherapy and Pharmacology. https://doi.org/10.1007/s00280-026-04924-7
Source records
- crossref · retrieved 2026-11-10T11:08:17.171Z